Drug Profile
Research programme: infertility and onclogy therapeutic biosimilars - Zydus Cadila
Alternative Names: Prod-5; Prod-6; Prod-7Latest Information Update: 28 Mar 2023
Price :
$50
*
At a glance
- Originator Zydus Cadila
- Class Antineoplastics; Infertility therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer; Infertility
Most Recent Events
- 28 Mar 2023 Discontinued - Preclinical for Infertility in India (unspecified route)
- 28 Mar 2023 Discontinued for Cancer in India (unspecified route)
- 01 Dec 2016 Early research in Cancer in India (Unspecified route)